Sarcomas Completed Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00112489Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerTreatment
NCT00003334Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractTreatment
NCT00003008Paclitaxel in Treating Patients With AIDS-Related Kaposi's SarcomaTreatment
NCT00020449Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaTreatment
NCT00217607Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryTreatment